Cycling for neurodegeneration
Nature Chemical Biology
July 14, 2009
A novel method of disrupting abnormal protein deposits in the brain associated with neurodegenerative disease is presented in a study published online this week in Nature Chemical Biology.
Neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's are characterized by the presence of protein aggregates in the brain that are thought to be toxic. These aggregates arise from abnormal protein-protein interactions and are not only physically obtrusive, but also block the natural flow of other proteins important for cellular function. Previous research has used small molecules or enzymes to disrupt these protein aggregates in ameliorating disease. Cyclic peptides offer an alternative to these previous strategies since they affect protein-protein interactions, a process that clearly goes awry in these diseases.
Susan Lindquist and colleagues studied a yeast model system of protein aggregation that shares biochemical features of neurodegenerative disease. They identified several cyclic peptides that rescued disease-induced cell death caused by protein aggregation in yeast. The cyclic peptides also rescued neurons from degeneration in a worm model of neurodegenerative disease. This strategy may be applicable in learning about the mechanism of these diseases and in creating potential treatments.
doi: 10.1038/nchembio.193
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature